Searches for those names return no results, The Verge found, but slight spelling changes still surface videos and TikTok's own suggestions point the way.
Recap by typeshit. Full story at The Verge.
A short clip from obesity doctor Nadolsky with his three pointers for people about to begin GLP-1 treatment. The details are in the video.
A general explainer on how GLP-1 receptor agonists affect blood sugar and appetite, with advice on support while taking them.
A sponsored-style look at compounded tirzepatide and semaglutide through telehealth firm Mochi Health, noting compounded drugs aren't FDA approved for safety or quality.
Among the items: Walmart plans free GLP-1 diabetes drugs for employees in 2027, and Verdiva Bio dropped a phase II oral GLP-1 study citing market changes.
ABC News' chief medical correspondent walks through the latest Novo Nordisk GLP-1 medication and what sets it apart from drugs already on the market.
The supplement ingredient is pitched by the company as a non-stimulant for cognition. Human trials only start in December 2026, with larger studies planned for 2027.
Loading…